Background/Aims: Spinal cord glioma is a highly aggressive malignancy that commonly results in high mortality due to metastasis, high recurrence and limited treatment regimens. This study aims to elucidate the effects of long non-coding RNA LINC01260 (LINC01260) on the proliferation, migration and invasion of spinal cord glioma cells by targeting Caspase recruitment domain family, member 11 (CARD11) via nuclear factor kappa B (NF-κB) signaling. Methods: The Multi Experiment Matrix (MEM) website was used for target gene prediction, and the DAVID database was used for analysis of the relationship between CARD11 and the NF-κB pathway. In total, 60 cases of glioma tissues and adjacent normal tissues were collected.
Introduction
Glioma, one of the most common types of primary brain tumors among adults, represents one of the most lethal and aggressive cancers [1] . Multiple chromosomal and genetic abnormalities are associated with glioma, resulting in highly aggressive tumors that will rapidly infiltrate, invade and destroy neighboring tissue, particularly in the spinal cord [2] . Low-grade gliomas are often associated with neurological disability [3] . Due to the high recurrence rate, infiltrative nature and limited treatment options, the prognosis of high-grade glioma remains poor [4] . Despite many advances in medical and surgical therapy in recent years, glioma remains a fatal disease, with overall poor survival [5] . Moreover, radiotherapy treatment for spinal cord glioma is associated with worsened outcomes [6] . Interestingly, one study provides new insight for understanding the function of the long non-coding RNA taurine up-regulated gene 1 (lncRNA TUG1) in cancer biology, with the potential of TUG1 overexpression in glioma therapy [7] .
As a relatively new class of non-coding RNAs, lncRNAs have been widely reported to function in different biological processes because of their role in gene expression [8] . Certain lncRNAs can regulate the effects of transcription factors by serving as co-regulators and may be involved in epigenetic regulation, including X-chromosome inactivation, and in chromatin and histone modification [9] . Furthermore, emerging evidence has revealed that lncRNAs have a close relationship with diverse malignancies and may act as tumor suppressors in different tumor types [10] . Caspase recruitment domain family, member 11 (CARD11), a scaffold protein that forms a complex with B cell lymphoma-10 and mucosaassociated lymphoid tissue (MALT1), is required for antigen receptor-triggered nuclear factor kappa B (NF-κB) activation in both B-and T-cells [11] . NF-κB transcription factors are often evolutionarily conserved, possibly coordinating regulators of inflammatory and immune responses and playing a pivotal role in metabolic and oncogenesis disorders [12] . For example, NF-κB signaling orchestrates several pivotal biological processes in cancer development and progression by inducting transcription of various target genes controlling the cell cycle, apoptosis, and invasion [13] [14] [15] . Importantly, LINC01260 is down-regulated in spinal cord glioma (GEO database GSE15824) and is co-expressed with CARD11 in various cancers, including skin cutaneous melanoma, liver hepatocellular carcinoma, kidney clear cell carcinoma, breast invasive carcinoma, brain lower grade glioma, prostate adenocarcinoma and glioblastoma multiforme [16] . Nonetheless, how LINC01260 targets CARD11 in spinal cord glioma remains unclear. This study was performed to explore the role of LINC01260 in the proliferation, migration and invasion of spinal cord glioma cells by targeting CARD11 via the NF-κB pathway.
Materials and Methods

Target gene prediction
The Multi Experiment Matrix (MEM, http://biit.cs.ut.ee/mem/) website was used for target gene prediction for LINC01260. MEM is a web-based tool for conducting co-expression queries among a large number of collections of gene expression experiments. MEM can provide access to hundreds of publicly available gene expression datasets of various tissues, diseases and conditions and is managed by both species and microarray platform types [17] . The specific approaches are shown at https://biit.cs.ut.ee/ beta_mem/help/mem_ismb_2009.pdf. In addition, the DAVID website (http://david.ncifcrf.gov/) was adopted for Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis to confirm the main biochemical metabolic and signaling pathways related to the obtained target genes.
Sample collection
Following verification of spinal cord glioma by pathological examination, 60 cases of spinal cord glioma and adjacent normal tissues were obtained after surgery from patients at Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University between 2007 and 2011. Among the patients, 34 were male and 26 female, with age range from 3 to 82 years. Prior to surgery, none of the patients had any distant spinal metastasis or was treated with other regimens. After collection of spinal cord glioma and adjacent tissues (2 cm on the verge) during surgery, a portion of the fresh samples were fixed in 10% formaldehyde solution (UFML04360, Shanghai JunruiBiotch Company, Shanghai, China) after extraction, and the remainder was preserved at -80°C for further experiments. All sample collections were approved by the patients via informed consent and were in accordance with the requirements of the Ethics Committee of Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University.
Immunohistochemistry
All tissue sections were placed in an incubator at 60°C for 1 h, dewaxed with xylene, dehydrated by a graded alcohol series and incubated in 3% H 2 O 2 (BD5024, Bioworld Technology Inc, Minneapolis, Minnesota, USA) at 37°C for 30 min. The sections were then washed4 times with phosphate-buffered saline (PBS) (2 min each time), and antigen retrieval was performed using the high-pressure method for 2 min. Next, the sections were placed in 0.01 M citric acid buffer (pH 6.0) and heated at 95°C for 20 min followed by immersion in 3% H 2 O 2 for 15 min to block exogenous peroxidase activity. The sections were blocked with normal goat serum working fluid (Ns01-01, Bai Taike Biotechnology Co., Ltd., Henan, China) at 37°C for 10 min. The diluted primary antibody, rabbit anti-human polyclonal antibody CARD11 (1: 500, bs-6201R, Bioss, Beijing, China), was added and incubated at 4°C overnight, followed by washing three times with PBS for 3 min. Next, the horseradish peroxidase (HRP)-labeled goat anti-rabbit secondary antibody working solution was added (1: 1000, A21020, Abbkine, California, San Francisco, CA, USA) and incubated at room temperature for 30 min, after which the sections were stained with diaminobenzidine (DAB) (3, 3-diaminobenzidine, AR1000, Wuhan Bude Biological Engineering Co., Ltd. Hubei, China). The sections were rinsed remove excess dye, and mounted. PBS, instead of the primary antibody, was used as a negative control (NC), and known positive sections were used as positive controls. Color development was observed under a microscope, with the cell membrane or cytoplasm of positively staining cells showing a tan color. Section images were captured under the microscope, and five randomly selected high-magnification fields with 100 cells were counted.. The average percentage of positive cells in each section was regarded as the positivity rate.
RNA isolation and quantitation
Total RNA was extracted from the spinal cord glioma and adjacent normal tissues preserved at -80°C according to the instructions of an miRNeasy Mini Kit (217004, Qiagen, Hilden, Germany); (A) 260 /A 230 and A 260 /A 280 ratios were evaluated using a Nanodrop 2000 micro-ultraviolet spectrophotometer (1011U, NanoDrop Technologies Inc., Wilmington, USA) for determination of the concentration and purity of the extracted total RNA. The obtained RNA was then reverse transcribed into cDNA according to the instructions of TaqMan MicroRNA Assays Reverse Transcription Primer (4427975, Applied Biosystems Inc. Carlsbad, CA, USA). The reaction conditions were 37°C for 30 min and 85°C for 5 s. The obtained cDNA was diluted to 50 ng/μl, and 2 μl was used for amplification in a 25-μl volume. Primers designed to amplify LINC01260, CARD11, Ki67, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-9, p53, NF-κBp50 and NF-κBp65 were synthesized by TaKaRa (Takara Biotechnology Ltd., Liaoning, China) ( Table 1) . Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was conducted using the ABI7500 quantitative PCR instrument (7500, ABI Company, Oyster Bay, NY, USA), with the following conditions: pre-denaturation at 95°C for 10 min and 40 cycles of denaturation at 95°C for 10 s, annealing at 60°C for 20 s, and extension at 72°C for 34 s. The fluorescence quantitative PCR 20-μl reaction mixture consisted of 10 μl of SYBR Premix . Each group of experiments was repeated 3 times (mRNA expression was detected after 48 h of transfection, and the experimental methods were the same as those presented above).
Western blot analysis
The spinal cord glioma and adjacent normal tissues preserved at -80°C were placed in a glass grinder with 1 ml of tissue lysis buffer (BB-3209, Beibo Biology, Shanghai, China) for homogenization at 3000 r/min until fully dissociated. The tissues were then placed in an ice bath for 30 min, with shaking once every 10 min, and centrifuged (12000 r/min) for 20 min at 4°C; the lipid layer discarded. The liquid supernatant was collected for protein concentration detection using a bicinchoninic acid (BCA) kit (20201ES76, Yeasen Inc, Shanghai, China); deionized water was used for adjusting the protein content to 30 μg of protein/lane. Each group of samples was mixed with the corresponding amount of 5 × sodium dodecyl sulfate (SDS) loading buffer, boiled at 100°C for 5 min, cooled on ice and centrifuged. The proteins were separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE), with a 5% stacking gel, and transferred to nitrocellulose membranes. The membranes were blocked overnight with 5% skim milk powder at 4°C. Diluted (1: 500) primary rabbit anti-human polyclonal antibodies, including anti-CARD11 (bs-6201R), -Ki67 (bs-5570R), -N-cadherin (bs-1172R), E-cadherin (bs-10009R), MMP-9 (bs-4593R), NF-κBp65 (bs-0465R) and NF-κBp50 (bs-1194R) (all antibodies were purchased from Beijing Boao Sen Biotechnology Co., Ltd., Beijing, China), and diluted rabbit anti-rat polyclonal p53 (1: 1000, ABP50382, Abbkine, California, USA) and anti-β-actin (ABP57456, Abbkine, California, USA) antibodies were added and incubated overnight. The membrane was then washed 3 times with PBS at room temperature (5 min/ time), and the diluted HRP-labeled IgG goat anti-rabbit secondary antibody (1: 10000, A21020, Abbkine, California, USA) was added for l h at 37°C, after which the membrane was washed3 times with PBS at room temperature (5 min/time). The membrane was incubated with enhanced chemiluminescence (ECL) solution (ECL808-25, Biomiga, San Diego, CA, USA) at room temperature for 1 min. The liquid was then removed, and the membrane was covered with preservative film and exposed to X-ray film (36209ES01, Qianchen Biological Technology Co., Ltd., Shanghai, China). The ratio between the gray value of the target band and the internal reference band was used as the relative expression level of the protein, with β-actin as an internal reference. Each group of experiments was repeated 3 times; cells were examined after transfection for 72 h.
Cell culture
The human glioma cell line U251 (PT-1903, ATCC, Rockefeller, Maryland, USA) was seeded in Dulbecco's modified Eagle medium (DMEM) (GNM-12800, Shanghai Chemical Science and Technology Co., Ltd., Shanghai, China) containing 10% fetal bovine serum (FBS) and incubated in a 5% CO 2 incubator with saturated humidity at 37°C. The cells were subcultured once every 2 -3 d, and cells in logarithmic growth phase were collected for use. 
Construction of overexpression and RNA interference expression vectors
Based on the known transcript sequences of the LINC01260 and CARD11 genes in GenBank, the fulllength sequences of LINC01260, CARD11 and small inhibitory (siRNA; 3 pairs of siRNA sequences were designed for each gene), as well as negative control (NC) sequences, were designed online using the Ambion website and were synthesized by Shanghai Ji Kai Gene Biology Co., Ltd. (Shanghai, China). The correct sequence was cloned into the vector pcDNA3.1 (VPI0001, Invitrogen Inc., Carlsbad, CA, USA) at Hind III and XHo I restriction sites and ligated at 16ºC for 1 h. The ligation product was added to competent Escherichia coli DH5α cells (D9052, Takara Biotechnology Ltd., Liaoning, China). Resistant colonies were screened and identified by colony PCR, and positive clones were sequenced. The plasmid was stored at -20°C.
Cell transfection and grouping U251 glioma cells in logarithmic growth phase were digested with 0.25% trypsin (25200056, Gibco, Grand Island, NY, USA), re-suspended in serum M199 medium containing 10% FBS to a concentration of 1 × 10 5 cells/ml, and inoculated in a 6-well culture plate. When confluence reached 80%, transfection was conducted. Next, 200 μl of serum-free Opti-MEM medium (31985, Gibco, Grand Island, NY, USA) was used to dilute 6 μl of Lipofectamine 2000 (11668-019, Invitrogen Inc., Carlsbad, CA, USA) and 2 μg of the target plasmid respectively, followed by even mixing and incubation at room temperature for 10 min. The two solutions were subsequently mixed and incubated at room temperature for 20 min. The medium in the 6-well plate was discarded, and 180 μl of Opti-MEM medium was added to each well, followed by addition of the transfection mixture and incubation at 37°C in a 5% CO 2 incubator for 18 h. Next, new medium (INV-00002, INNOVATE, Jiangsu, China) was added for further incubation for 24 h. The cells were collected for subsequent experiments. The cells were divided into the blank group (no transfection), NC group (transfected with the LINC01260 NC sequence), LINC01260 vector group (transfected with the LINC01260 overexpression plasmid), CARD11 vector group (transfected with the CARD11 overexpression plasmid), siRNA-LINC01260 group (transfected with the LINC01260 siRNA-CARD1 plasmid), siRNA-CARD11 group (transfected with the siRNA--CARD1 plasmid), LINC01260 vector + CARD11 vector group (transfected with LINC01260 and CARD11 overexpression plasmids) and siRNA-LINC01260 + siRNA-CARD11 group (cotransfected with LINC01260 and siRNA-CARD1 plasmids).
Dual-luciferase reporter assay
The bioinformatics prediction website lncRNA Targets (http://www.herbbol.org:8001/lrt/) was employed to analyze LINC01260 target genes using lncRNA (query sequences) and RNA (subjects) sequences. All of the results were presented in a table with green and red colors based on the ΔG/n threshold value, the cutoff value. Good stability of internal base pairs for two sequences reflects the relatively stable combination between the query and subject [18] . HEK-293T (AT-1592, ATCC, Manassas, VA, USA) cells were seeded in a 24-well plate and cultured for 24 h. A CARD11 dual-luciferase reporter gene plasmid (pmiRRB-CARD11-3'UTR) was constructed and co-transfected with the LINC01260, siRNA-LINC01260 or NC plasmid into HEK-293T cells. Following transfection for 48 h, the medium was discarded, and the cells were washed twice with PBS, collected and lysed. Luciferase activity was measured using a dual-luciferase reporter assay system (Dual-Luciferase® Reporter Assay System, E1910, Promega Corporation, Madison, WI, USA). Firefly luciferase activity was measured by adding 50 μl of firefly luciferase solution for every 10 μl of the cell sample; 50 μl of Renilla luciferase was also added. The ratio of luciferase activity to Renilla activity was regarded as the relative luciferase activity. The experiment was repeated three times.
The 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay
Following transfection for 24 h, cells were collected, washed twice with PBS and digested with 0.25% trypsin to prepare a single-cell suspension. Following cell counting, 3 × 10 4 -5 × 10 4 cells were inoculated per well (0.1 ml) into a 96-well plate, with 6 duplicate wells for each plate. The cells were then placed in an incubator, and cell adhesion was examined at 0 h, 24 h, 48 h and 72 h. Then, 20 μl of 0.5% MTT solution (M2128, Sigma-Aldrich Chemical Company, St Louis MO, USA) was added to each well, and the samples were cultured for another 4 h, after which the supernatant was removed. After this step, 100 μl of dimethyl sulfoxide (DMSO, D5879-100ML, Sigma-Aldrich Chemical Company, St Louis MO, USA) was added to each well, and the plate was slightly shaken for 10 min to completely dissolve the formazan crystals produced by living cells. A microplate reader (BS-1101, DetieExperimental Equipment Co., Ltd., Nanjing, Jiangsu, China) Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry was used to detect the optical density (OD) value for each well at 492 nm. Each experiment was repeated three times, and a cell viability curve was drawn with the time point as the abscissa and the OD value as the ordinate.
Flow cytometry
Propidium iodide (PI) single staining: following transfection for 24 h, cells were collected, digested with 0.25% trypsin, and centrifuged (1000 r/min) for 5 min; the pellet was washed three times with cold PBS. The cells were then re-suspended in PBS at a concentration of 1 × 10 5 cells/ml and fixed with 2 ml of -20°C pre-cooled 75% ethanol alcohol at 4ºC for 30 min. Following this step, the cells were centrifuged, and the ethanol removed; the samples were washed twice with PBS. Next, 100 μl of RNase A was added, and the samples were protected from light in a 37°C water bath for 30 min; 400 μl of PI dye (P4170, SigmaAldrich Chemical Company, St Louis MO, USA) was added and mixed at 4°C for 30 min, away from light. Flow cytometry (CA 92821, CytoFLEX, Beckman Coulter Life Sciences, Brea, CA, USA) was performed to record red fluorescence for detection of the cell cycle at an excitation wavelength of 488 nm. The experiment was repeated three times.
Annexin-V/PI double labeling method: following transfection for 48 h, cells were digested with 0.25% trypsin (PYG0107, Wuhan Boster Biological Technology Co., LTD., Hubei, China) without ethylene diamine tetraacetic acid (EDTA), collected in a flow cytometry tube, and centrifuged; the supernatant was discarded. The cells were then washed three times in cold PBS and centrifuged again, with the supernatant discarded. According to the instructions of Annexin-V-FITC Apoptosis Detection Kit (K201-100, Biovision, CA, USA), the Annexin-V-FITC dye was prepared with Annexin-V-FITC, PI, 4-(2-hydroxyethyl)-1-piperazinethane sulfonic acid (HEPES) buffer at a ratio of 1: 2: 50. Each 100 μl of dye solution was used to resuspended 1 × 10 6 cells. The samples were shaken and mixed. Following incubation at room temperature for 15 min, 1 ml of HEPES buffer solution was added. FITC and PI fluorescence was detected using 615-nm and 690-nm bandpass filters at a wavelength of 488 nm, and apoptosis was assessed (the experiment was repeated 3 times). The flow cytometry scatter diagram shows that the right lower quadrant contained early apoptotic cells, the upper right quadrant contained necrotic and apoptotic cells, the upper left quadrant contained mechanically injured cells or necrotic cells, and the left lower quadrant contained living cells. Apoptosis rate (%) = percentage of early apoptosis + percentage of late apoptosis. The experiment was repeated three times.
Wound-healing assay
Following transfection for 48 h, cells were digested at a density of 5 × 10 5 cells/ml; 100 μl of the cell suspension was seeded in a 24-well plate and cultured at 37°C in 5% CO 2 to form a cell monolayer. The cells were then scratched and washed with PBS. The medium was replaced with one (RPMI 1640, 350-030-CL, Wisent Biological Technology Co., Ltd., Jiangsu, China) containing 10 g/L bovine serum albumin (BSA) (9998S, Shanghai Beinuo Biological Technology Co., Ltd., Shanghai, China) and 1% FBS. The migration distance was measured under a microscope. Following 24 h of culture, the medium was replaced by fresh medium (RPMI 1640) supplemented with 10% FBS for 24 h. The relative distance of cell migration towards the injured area was measured under a microscope. The experiment was repeated three times.
Transwell assay
Following 48 h of transfection, cells were starved in serum-free medium for 24 h, digested with trypsin, and washed twice with PBS. Serum-free Opti-MEMI medium containing 10 g/L bovine serum albumin (BSA; 9998S, Shanghai Beinuo Biotechnology Co., Ltd., Shanghai, China) was used to re-suspend the cells at the density of 5 × 10 5 cells/ml. Experiments were performed using a 24-well plate and an 8-μm Transwell chamber (3422, Beijing You Nikon Biotechnology Co., Ltd., Beijing, China), with 3 chambers for each group, and 100 μl of cell suspension was added per well. A total of 600 μl of 10% RPMI 1640 medium (350-030-CL, Visent Biotechnology Co., Ltd., Jiangsu, China) was added to the lower chamber, and the plates were placed in a 5% CO 2 incubator at 37°C. For the migration test, the cells were fixed after 48 h with 4% paraformaldehyde for 30 min and subsequently placed in 0.2% Triton X-100 (HFH10, Invitrogen Inc., Carlsbad, CA, USA) solution for 15 min; the cells were then stained with 0.05% crystal violet (71019944, Shanghai Rongbai Biotechnology Co., Ltd., Shanghai, China) for 5 min. For the invasion test, 50 μl of Matrigel matrix gel (YB356234, Shanghai Yubo Biotechnology Co., Ltd., Shanghai, China) was added to cover the Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry chamber before the experiment. After 48 h, the above method of fixing and staining was applied. The number of stained cells was counted under an inverted microscope. Five fields were randomly selected to count the cell number, and the result was expressed as a mean value. The experiment was repeated three times.
Xenograft tumors in nude mice
BALB/c nude mice aged approximately 4 weeks were purchased from the Experimental Animal Center of the Third Military Medical University (Chongqing, China). All mice were housed in laminar flow cabinets under specific pathogen-free (SPF) conditions with a constant temperature (24°C -26°C) and humidity (45% -55%). Forage and drinking water were given to mice after high-temperature disinfection. Then the mice were allocated into blank, NC, LINC01260 vector, CARD11 vector, siRNA-LINC01260, siRNA-CARD11, LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (5 mice in each group). Following transfection of U251 glioma cells, the subcutaneous part of the nude mice was injected with 200 μl of a U251 cell suspension containing 1 × 10 6 cells for each group. The maximum diameter (a) and minimum diameter (b) of the tumors that appeared were measured using a Vernier caliper. Tumor volume was calculated according to the formula V = a × b 2 × 0.5 [19] , with an interval of 5 d, 4 times each. Later, tumor growth curves were drawn. The mice were killed using the cervical dislocation method. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Statistical analysis
The data were processed with the SPSS 21.0 statistical package (IBM, Armonk, NY, USA). Measurement data were normally distributed, and the results are expressed as the mean ± standard deviation. Comparison between expression of different factors in cancer tissues and adjacent normal tissues was performed using the t-test. Comparisons among multiple groups were achieved using one-way analysis of variance (ANOVA), and those between two groups were performed by the least significant difference (LSD) test. In addition, repeated measures ANOVA was employed to assess the results of the MTT assay and tumor growth curves, and the chi-square test was used for comparisons of CARD11 protein expression between groups. A significant difference was considered at p < 0.05.
Results
CARD11 is predicted as a target gene of LINC01260
According to the MEM website, CARD11 was predicted as a target gene of LINC01260 (Table 2 ). Its participation in the NF-κB signaling pathway (Fig 1) suggested that CARD11 is a target gene of LINC01260.
Higher rate of CARD11 expression is found in glioma tissues
Immunohistochemistry was employed to determine CARD11 protein expression. The CARD11 protein was primarily found in the cytoplasm, with a small amount in the plasma membrane. Positive cells stained brown or tan. Compared with adjacent normal tissues [56.7% (34/60)], the rate of CARD11 protein expression was clearly increased in glioma tissues [21.7% (13/60)] (p < 0.05) (Fig 2) . Based on these findings, CARD11 is expressed at a higher level in glioma tissues.
LINC01260, E-cadherin and p53 are expressed at low levels and CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50 at high levels in glioma tissues RT-qPCR and western blot analyses were conducted to determine expression of LINC01260, E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50. Compared with adjacent normal tissues, LINC01260 expression was decreased 0.69-fold, and mRNA and protein expression of E-cadherin was reduced 0.4-fold and 0. 
NF-κBp50 (mRNA 1.89-fold; protein 2.58-fold) were markedly increased in glioma tissues (p < 0.05) (Fig 3) . These results provide evidence that LINC01260, E-cadherin and p53 are expressed at low levels and that CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50 are expressed at high levels in glioma tissues.
LINC01260 inhibits CARD11 activity
Dual-luciferase reporter gene assays and bioinformatics prediction were applied to analyze the relationship between LINC01260 and CARD11. Based on bioinformatics prediction, the binding site for LINC01260 and CARD11 were present in the CARD11 3' untranslated region (UTR), with a free energy between of ΔG = -76. 38 and ΔG/n = -0.066. Therefore, CARD11 was confirmed as a target gene for LINC01260. Compared with the NC group, relative luciferase activity was significantly decreased in the LINC01260 vector group and significantly increased in the siRNA-LINC01260 group (p < 0.05), indicating that LINC01260 can target CARD11 and may inhibit CARD11 activity (Fig 4) .
LINC01260 represses CARD11 expression and
inactivates the NF-κB pathway RT-qPCR and western blot analyses were conducted to assess expression of LINC01260, Fig. 1 . CARD11 is involved in the NF-κB signaling pathway.Notes: CARD11, caspase recruitment domain family, member 11; NF-κB, nuclear factor-kappa B. Notes: CARD11, caspase recruitment domain family, member 11; NF-κB, nuclear factor-kappa B. B, Luciferase activity determined by a dualluciferase reporter assay for the relationship between LINC01260 and CARD11; *, p<0.05, compared with the NC group (n = 3). NC, negative control; LINC01260, non-coding RNA LINC01260; CARD11, caspase recruitment domain family, member 11. 
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Although the LINC01260 vector and siRNA-CARD11 groups showed no notable differences in mRNA and protein expression of E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NFκBp65 and NF-κBp50 (all p > 0.05), the CARD11 vector group did exhibit altered expression of CARD11 (mRNA expression increased 1. and p53 (mRNA 1.80-fold; protein 1.74-fold) was observed. However, the data showed no difference between the CARD11 vector and siRNA-LINC0126 groups (p > 0.05), Moreover, mRNA and protein expression of CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65, NF-κBp50, E-cad and p53 did not differ between the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05) or between the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05) (Fig 5) . These findings reveal that LINC01260 represses CARD11 and inactivates the NF-κB signaling pathway.
Overexpressed LINC01260 or siRNA-CARD11 decreases cell proliferation
The MTT assay was performed to evaluate cell proliferation. The proliferation of U251 glioma cells in each group was accelerated from 24 h, 48 h to 72 h. There was no remarkable difference in proliferation of U251 glioma cells between the blank and NC groups, the LINC01260 vector and siRNA-CARD11 groups, the CARD11 vector and siRNA-LINC01260 groups, or the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05). Compared with the blank and NC groups, the proliferation of U251 glioma cells was markedly decreased in the LINC01260 vector and siRNA-CARD11 groups (p < 0.05) and was observably increased in the CARD11 vector and siRNA-LINC01260 groups (p < 0.05). However, there was no significant change in the proliferation of U251 glioma cells between Fig. 5 . LINC01260 overexpression reduces the expressions of E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50 in U251 cells after transfection, as verified by RT-qPCR and western blot analyses. Notes: A, LINC01260 expression and mRNA expressions of E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50 in U251 cells among eight groups. B, Protein expression of E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50 among eight groups in U251 cells. C, Western blot analysis results for E-cadherin, p53, CARD11, Ki67, N-cadherin, MMP-9, NFκBp65 and NF-κBp50 among eight groups in U251 cells; *, p<0.05, compared with blank and NC groups (n = 3). NC, negative control; MMP, matrix metalloproteinase; LINC01260, non-coding RNA LINC01260; CARD11, caspase recruitment domain family, member 11; NF-κB, nuclear factor-kappa B; RT-qPCR, reverse transcription quantitative polymerase chain reaction. (Fig 6) . Therefore, it is suggested that up-regulation of LINC01260 or down-regulation of CARD11 can inhibit glioma cell proliferation.
Overexpressed LINC01260 or siRNA-CARD11 enhances glioma cell cycle and apoptosis
Flow cytometry was used to examine the cell cycle and apoptosis. There was no remarkable difference in cell cycle distribution between the blank and NC groups, the LINC01260 vector and siRNA-CARD11 groups, the CARD11 vector and siRNA-LINC01260 groups, or the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05). Compared with the blank and NC groups, the number of cells in G1 phase was notable increased, but the number in S and G2 phases was remarkably decreased in the LINC01260 vector and siRNA-CARD11 groups (p < 0.05). The number of cells in G1 phase was significantly reduced but that in S and G2 phase was markedly elevated in the CARD11 vector and siRNA-LINC01260 groups (p < 0.05). Conversely, no substantial change was observed between the LINC01260 vector + CARD11 vector and the siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05) (Fig 7) .
The results of Annexin V/PI double staining revealed no remarkable difference in apoptotic rate between the blank (5.71 ± 0.60)% and NC (5.90 ± 0.60)% groups, the LINC01260 vector (18.05 ± 1.90)% and siRNA-CARD11 (19.00 ± 2.10)% groups, the CARD11 vector (1.05 ± 0.30)% and siRNA-LINC01260 (1.10 ± 0.25)% groups, or the LINC01260 vector + CARD11 vector (6.00 ± 0.80)% and siRNA-LINC01260 + siRNA-CARD11 (5.86 ± 0.70)% groups (all p > 0.05). Compared with the blank and NC groups, the apoptotic rate of U251 glioma cells was substantially elevated in the LINC01260 vector and siRNA-CARD11 groups (p < 0.05) but was strongly reduced in the CARD11 vector and siRNA-LINC01260 groups (p < 0.05). No significant change in the apoptotic rate of U251 glioma cells was observed between the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05) (Fig 8) . These findings indicate that up-regulation of LINC01260 or down-regulation of CARD11 enhances glioma cell apoptosis.
Overexpressed LINC01260 or siRNA-CARD11 inhibits cell migration and invasion
Wound-healing (Fig 9A) and Transwell (Fig 9B) assays were performed to identify cell migration and invasion. No marked difference in migration and invasion of U251 
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Cellular Physiology and Biochemistry glioma cells between the blank and NC groups, the LINC01260 vector and siRNA-CARD11 groups, the CARD11 vector and siRNA-LINC01260 groups, or the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05) was found. Compared with the blank and NC groups, cell migration and invasion abilities were substantially decreased in the LINC01260 vector and siRNA-CARD11 groups (p < 0.05) and elevated in the CARD11 vector and siRNA-LINC01260 groups (p < 0.05).
There was no significant change in cell migration and invasion between the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05). Taken together, these results reveal that up-regulation of LINC01260 or down-regulation of CARD11 suppresses glioma cell migration and invasion.
Overexpression of LINC01260 or siRNA-CARD11 inhibits tumor growth in nude mice
Xenograft tumors in nude mice were employed to observe tumor growth (Fig 10) . Compared with the blank and NC groups, tumor growth was clearly inhibited in the LINC01260 vector and siRNA-CARD11 groups and enhanced in the CARD11 Fig. 9 . U251 glioma cell migration and invasion after transfection among eight groups, as confirmed by wound-healing and Transwell assays. Notes: A, Cell migration after transfection among the eight groups, as detected by the woundhealing assay. B, Cell invasion conditions after transfection among the eight groups, as confirmed by the Transwell assay; *, p<0.05, compared with blank and NC groups (n = 3). NC, negative control; LINC01260, non-coding RNA LINC01260; CARD11, caspase recruitment domain family, member 11. vector and siRNA-LINC01260 groups (p < 0.05), though no change was found between the LINC01260 vector + CARD11 vector and siRNA-LINC01260 + siRNA-CARD11 groups (p > 0.05). In addition, there was no marked change in tumor growth in the NC group in comparison to the blank group (p > 0.05). The results suggest that overexpression of LINC01260 or siRNA-CARD11 represses tumor growth in nude mice.
Discussion
Glioma is an aggressive brain tumor that exhibits high resistance to chemotherapy [20] . The functional effects of lncRNAs have been verified, including their role as key regulators of translational and transcriptional products that influence cellular functions [21] [22] [23] . The present study investigated the effects of LINC01260 on the proliferation, migration and invasion of spinal cord glioma cells. We found that overexpression of LINC01260 inhibited spinal cord glioma cell proliferation, migration and invasion by targeting CARD11 via suppression of NF-κB signaling.
The glioma tissues in this study presented decreased expression of LINC01260 but elevated mRNA and protein expression of CARD11 in comparison with adjacent normal tissues. A previous study indicated the potential effects of lncRNAs on the biogenesis, differentiation and development of gliomas, providing an obvious platform for glioma studies [24] . Moreover, lncRNAs might contribute to brain development, and some specific differentially expressed lncRNAs might exert strong effects on the pathogenesis of glioblastoma [25] . Furthermore, specific lncRNAs may serve as tumor inhibitors or oncogenes, which have similar functions [26] . For example, expression of Maternally Expressed Gene 3 (MEG3) is markedly reduced in glioma tissues compared to adjacent normal tissues, and MEG3 was found to enhance apoptosis and impair proliferation of U87 and U251 glioma cells [27] , which was consistent with the results of the present study. In addition, it has been reported that up-regulation of the lncRNA HOXA transcript at the distal tip (HOTTIP) ameliorates glioma cell apoptosis and attenuates proliferation [28] . Additionally, CARD11 is predicated to be a target gene of LINC01260 and to be associated with NF-κB pathway regulation. LncRNAs are known to affect epigenetics and to regulate gene expression [29] , and novel CARD-containing proteins, including CARD11 and CARD14, modulate activation of the NF-κB pathway [30] . Importantly, somatic gain-of-function (GOF) mutations influencing CARD11 have been observed in various forms of diffuse large B-cell lymphoma, in association with constitutive activation of the NF-κB pathway [31] [32] [33] . Taken together, these findings indicate that overexpression of LINC01260 and inhibition of CARD11 can suppress glioma.
Moreover, our study revealed that overexpression of LINC01260 and down-regulation of CARD11 might result in increases in expression of E-cadherin and p53 but reductions in expression of Ki67, N-cadherin, MMP-9, NF-κBp65 and NF-κBp50. E-cadherin is well documented as a tumor suppressor, with reduced expression in various cancer types, and E-cadherin levels in cancer patients are strongly connected to recurrence, metastasis, and prognosis of malignancies [34] . Up-regulation of N-cadherin is considered an important factor for tumor formation during the early stages of progression, and it has been demonstrated that N-cadherin levels are important in glioma, serving as a prognostic indicator for patients with high-grade tumors [35] . In addition, a previous meta-analysis suggested that MMP-9 is strongly associated with poor (5 years) prognosis and that MMP-9 detection in glioma tissue should be considered routine in clinical practice of pathology departments [36] . Moreover, neuronal cell death activated by p53 has been demonstrated in various neurodegenerative diseases; activated p53 has been detected in injured spinal neurons [37] , and Ki67 immunohistochemistry is a widely applied marker for tumor proliferation [38] . Together with their associated signaling networks, lncRNAs have emerged as novel players in the regulation and induction of the endothelial-mesenchymal transition (EMT) during metastasis [39, 40] . Moreover, many growth factors, including epidermal growth factor, fibroblast growth factor, vascular endothelial growth factor and related signaling proteins such as Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry NF-κB, PI3K/Akt, Hedgehog, Wnt and Notch, are involved in triggering and participating in EMT [41] . Furthermore, NF-κB is involved in prostatic disease progression (neoplasic and inflammatory) [42] , and it has been shown that the oncogenic risk of constitutive NF-κB activation due to germline CARD11 gain-of-function (GOF) mutations might elevate B-cell malignancy resulting from a larger number of naïve B cells [43] . The NF-κB transcription factor family has great effects on many inflammatory and immune responses, including the response to cancer [44] . Although the specific mechanism of lncRNAs is well understood, most lncRNAs exert their biological function via interaction with other molecules [45] , such as microRNAs, other lncRNAs, genomic DNA, and, in particular, proteins involved in vital pathways such as NF-κB signaling [45] . These findings provide evidence that overexpression of LINC01260 and inhibition of CARD11 may inhibit the development of spinal cord glioma via the NF-κB pathway. Furthermore, the results of this study demonstrate that overexpression of LINC01260 or siRNA-CARD11 might promote apoptosis but repress proliferation and invasion. CARD11 might interact with the pro-apoptotic protein Bcl-10, and CARD11 overexpression may enhance NF-κB activation [46] . In addition, oncogenic mutations in CARD11 are reportedly related to several types of lymphoma progression [31] , and CARD11 expression in leukocytes suggests that it might influence immune/inflammatory responses to epithelial ovarian cancer [44] . Thus, we conclude that suppression of CARD11 suppresses proliferation and invasion and facilitates apoptosis of glioma cells via the NF-κB pathway.
Our study demonstrated that overexpression of LINC01260 inhibits spinal cord glioma cell proliferation, migration and invasion by targeting CARD11 via repression of NF-κB signaling. These findings might provide new therapeutic targets for spinal cord glioma. Further work will attempt to address the potential prognostic utility of this biomarker.
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